| Gene symbol | CD70 | Synonyms | CD27-L, CD27L, CD27LG, LPFS3, TNFSF7, TNLG8A | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19p13.3 | dbXrefs | |
| Description | CD70 molecule | ||||
| GTO ID | GTC3863 |
| Trial ID | NCT06383507 |
| Disease | Renal Cell Carcinoma | Ovarian Cancer | Cervix Cancer | Head and Neck Squamous Cell Carcinoma | Nasopharyngeal Carcinoma |
| Altered gene | CD70 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CHT101 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Phase I Clinical Study to Assess the Safety and Efficacy of CD70-targeted CAR-T in the Treatment of CD70-positive Refractory or Relapsed Solid Tumors |
| Year | 2024 |
| Country | China |
| Company sponsor | Zhejiang University |
| Other ID(s) | CHT101 |
| Cohort 1 | |||||||||||
|
|||||||||||